Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma Cells.
Murakami T, Nakazawa T, Natsume A, Nishimura F, Nakamura M, Matsuda R, Omoto K, Tanaka Y, Shida Y, Park YS, Motoyama Y, Nakagawa I, Yamada S, Tamura K, Takeshima Y, Takamura Y, Wakabayashi T, Nakase H.
Murakami T, et al. Among authors: omoto k.
Anticancer Res. 2018 Sep;38(9):5049-5056. doi: 10.21873/anticanres.12824.
Anticancer Res. 2018.
PMID: 30194149